Sugi Predict

Sugi Predict / Compounds / SCHEMBL19866461

SCHEMBL19866461

SCHEMBL19866461

C#C[C@@]12OSO[C@@H]1[C@@](CCl)(COP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)O[C@H]2n1cnc2c(N)ncnc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAP Q12884 2/20 0.42
▸ STING1 Q86WV6 4/20 0.38
▸ AHCY P23526 4/20 0.36
▸ ADORA2A P29274 2/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ P2RX1 P51575 1/20 0.32
▸ P2RX3 P56373 1/20 0.32
▸ P2RX4 Q99571 1/20 0.32
▸ NT5E P21589 1/20 0.32
▸ DNPH1 O43598 1/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ TRPM2 O94759 1/20 0.32
▸ LDHA P00338 1/20 0.32
▸ ADRB2 P07550 1/20 0.32
▸ FBP1 P09467 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ P2RY2 P41231 1/20 0.32
▸ P2RY1 P47900 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19866534 0.94 FAP (0.42) FAPSTING1AHCYADORA2AADORA3
SCHEMBL17358552 0.89 FAP (0.42) FAPSTING1AHCYADORA2AADORA3
SCHEMBL18672164 0.89 FAP (0.42) FAPSTING1AHCYADORA2AADORA3
SCHEMBL16368205 0.88 FAP (0.41) FAPSTING1AHCYADORA2AADORA3
SCHEMBL18672175 0.87 FAP (0.41) FAPSTING1AHCYADORA2AADORA3
SCHEMBL16368204 0.85 FAP (0.45) FAPSTING1AHCYADORA2AADORA3
SCHEMBL19993807 0.82 FAP (0.42) FAPSTING1AHCYADORA2AADORA3
SCHEMBL16368196 0.81 FAP (0.41) FAPSTING1AHCYADORA2AADORA3
SCHEMBL19993778 0.81 FAP (0.43) FAPSTING1AHCYADORA2AADORA3
SCHEMBL19993729 0.80 FAP (0.45) FAPSTING1AHCYADORA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210106604-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Pharmaceuticals, Inc. 2021-04-15 — — US disclosed
US-10370401-B2 Substituted nucleosides, nucleotides and analogs thereof Janssen Biopharma, Inc. (US) 2019-08-06 — — US disclosed
US-20180044369-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Biopharma, Inc. 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044369-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF PNP, NT5C3B, NUDT1 FAP 366/4885STING1 272/4885AHCY 443/4885
US-10370401-B2 Substituted nucleosides, nucleotides and analogs thereof PNP, NT5C3B, NUDT1 FAP 366/4885STING1 272/4885AHCY 443/4885
US-20210106604-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF PNP, NUDT1, NT5C3B FAP 640/4885STING1 255/4885AHCY 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback